Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer
Narita, Yusuke, Matsushima, Yukiko, Shiroiwa, Takeru, Chiba, Koji, Nakanishi, Yoichi, Kurokawa, Tatsuo, Urushihara, HisashiТом:
90
Мова:
english
Журнал:
Lung Cancer
DOI:
10.1016/j.lungcan.2015.07.006
Date:
October, 2015
Файл:
PDF, 676 KB
english, 2015
File converter
Більше результатів пошуку
More benefits 
